Juan Carlos Cardet, AAAAI 2022: Reducing Severe Asthma Exacerbations in the PREPARE Study
We were delighted to talk with Dr. Juan Carlos Cardet (University of South Florida, Tampa, FL, USA) to discuss the PREPARE study, testing a Patient-Activated Reliever-Triggered Inhaled Corticosteroid (ICS) Strategy (PARTICS) in African American/Black and Hispanic/Latinx patients.
The abstract ‘Successfully Reducing Severe Asthma Exacerbations and Improving Asthma Control in a Pragmatic Study in African American/Black (AA/B) and Hispanic/Latinx (H/L) Patients with Moderate-Severe Asthma (PREPARE).’ was presented at AAAAI 2022, 25-28 February.
- Could you tell us a little about the health burden of asthma in African American/Black and Hispanic/Latinx patients? (0:11)
- What was the rationale for and design of the study you are presenting? (1:25)
- What were the outcome measures of the study and how well were they achieved? (2:43)
- What will be the impact of these findings on future clinical practice? (9:46)
- What questions remain unanswered and what future studies are planned? (12:00)
Disclosures: Juan Carlos Cardet discloses receiving grant/ research support from NIH/NIAID, ALA/AAAAI; has served on advisory boards for GSK, Genentech and AstraZeneca; and has received honoraria from GSK, Genentech and AstraZeneca.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the AAAAI annual meeting 2022.
Share this Video
Related Videos In Asthma
Barbara Yawn, CHEST 2022: The role of respiratory specialists in herpes zoster vaccination
Herpes Zoster (HZ) infection is a vaccine-preventable disease that occurs when a previous infection with varicella-zoster virus (VZV) is reactivated; patients with chronic obstructive pulmonary disease (COPD) and asthma have suppressed immunity and therefore are at a higher risk of being infected and experiencing complications. We caught up with Dr. Barbara Yawn (University of Minnesota, […]
Barbara Yawn, CHEST 2022: Herpes zoster vaccination in people with asthma or chronic obstructive pulmonary disease
Herpes Zoster (HZ) infection is a vaccine-preventable disease that occurs when a previous infection with varicella-zoster virus (VZV) is reactivated; patients with chronic obstructive pulmonary disease (COPD) and asthma have suppressed immunity and therefore are at a higher risk of being infected and experiencing complications. touchRESPIRATORY were delighted to speak with Dr. Barbara Yawn (University […]
Cristiano Caruso, ERS 2022: 2 Year Findings from the REALITI-A Study of Mepolizumab in Severe Asthma
REALITI-A was an international, prospective, observational cohort study, investigating the real-world corticosteroid-sparing effect of mepolizumab in severe asthma. touchRESPIRATORY caught up with Dr. Cristiano Caruso (Columbus Hospital, Fondazione Policlinico A. Gemelli, IRCCS, Rome, Italy) to discuss the aims, design, eligibility criteria and the 2 year findings from REALITI-A. The abstract ‘International, prospective study of mepolizumab […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!